• Home
  • >>>>>>>>>>>>> 2026 & BEYOND MASTER PLAN >>>>>>>>>>>>>>>>
  • Virtual Data Room (VDR) for Strategic Customized Slide Decks
  • TRAINABLE DATA ASSETS IN CORPORATE LEGACY & ORGANIZATION’s STRATEGIC MEMORY (2012 – 2025)
  • 2.0 LPBI Executive Summary
  • 1.0 LPBI Executive Summary
  • Founder’s Vision
  • Portfolio of IP Assets
  • Knowledge PORTALS System (KPS)
  • 1.0 LPBI – 2012-2020 VISTA
  • LPBI Group’s History
  • 2.0 LPBI – 2021-2025 VISION
  • BioMed e-Series
  • Press Coverage
  • Investor Relations
  • Our TEAM
  • Founder’s Bio
  • Funding, Deals & Partnerships
  • 1.0 LPBI Group News
  • 1.0 LPBI CALENDAR
  • 2.0 LPBI Group News
  • Testimonials about LPBI
  • DrugDiscovery @LPBI Group
  • Medical 3D Printing
  • e-VOICES Podcasting
  • LPBI Newsletters
  • Customer Surveys
  • Health Care INVESTOR’s Corner ($)
  • 2021 Summer Internship Portal
  • 2021-2025 Medical Text Analysis (NLP)
  • Artificial Intelligence: Genomics & Cancer
  • Blockchain Transactions Network Ecosystem
  • 1.0 LPBI Brochure
  • 2.0 LPBI Brochure
  • 2.0 LPBI – Calendar of Zooms
  • Coronavirus, SARS-CoV-2 Portal
  • LPBI India
  • SOP Web STAT
  • Synthetic Biology in Drug Discovery
  • Certificate One Year
  • NFT: Redefined Format of IP Assets
  • Audio English-Spanish: BioMed e-Series
  • Five Bilingual BioMed e-Series
  • Press Releases
  • Intangibles CIM
  • BioMed Audio Podcast Library @LPBI Group
  • Medical School Education: Use of LPBI Group’s Contents
  • ChatGPT + Wolfram PlugIn
  • Medicine with GPT-4 & ChatGPT
  • AGI, generativeAI, Grok, DeepSeek & Expert Models in Healthcare
  • Multimodal Healthcare Foundation Model
  • Cell Therapy in Regenerative Medicine, 2026 and Beyond
  • Contact Us

Leaders in Pharmaceutical Business Intelligence Group, LLC, Doing Business As LPBI Group, Newton, MA

Healthcare analytics, AI solutions for biological big data, providing an AI platform for the biotech, life sciences, medical and pharmaceutical industries, as well as for related technological approaches, i.e., curation and text analysis with machine learning and other activities related to AI applications to these industries.

Feeds:
Posts
Comments

Posts Tagged ‘Feynman lectures’

Richard Feynman, Genius and Laureate

Posted in Academic Publishing, tagged Feynman lectures, laws of physics on October 1, 2015| Leave a Comment »

Richard Feynman, Genius and Laureate

Larry H. Bernstein, MD, FCAP, Curator

LPBI

Richard Feynman Messenger Lectures (1964)

In these Messenger Lectures on “The Character of Physical Law,” originally delivered at Cornell University and recorded by BBC Nov. 9-19, 1964, physicist Richard Feynman offers an overview of selected physical laws and gathers their common features into one broad principle of invariance. From 1945 to 1950, Feynman taught theoretical physics at Cornell. He went on to accept a professorship at Caltech and was named co-winner of the 1965 Nobel Prize in physics.

Feynman participated in the Manhattan Project and like Enrico Fermi, he was able to perform complicated calculations with ease. His first wife was a best friend of his sister. He loved to play games with his children. He taught briefly in Brazil and enjoyed Brazilian music before returning to US. He was offered the Enrico Fermi chair in Physics at the University of Chicago, but did not accept.  He also was on the Committee that investigated the space aircraft disaster and performed an experiment on the discussion table that explained the problem, to the dismay of some politicians. He had cancer at the time.

When he gave these amazing lectures, it was said that the many physics students left the room perplexed, and professors and graduate students filled the hall.

in physics.

subscribe play all

1

Lecture 1 – Law of Gravitation | The Character of Physical Law | Richard Feynman

ADDED SEPTEMBER 24, 2015

2

Lecture 2 – The Relation of Mathematics to Physics | The Character of Physical Law | Richard Feynman

ADDED SEPTEMBER 24, 2015

3

Lecture 3 – The Great Conservation Principles | The Character of Physical Law | Richard Feynman

ADDED SEPTEMBER 24, 2015

4

Lecture 4 – Symmetry in Physical Law | The Character of Physical Law | Richard Feynman

ADDED SEPTEMBER 24, 2015

5

Lecture 5 – The Distinction of Past and Future | The Character of Physical Law | Richard Feynman

ADDED SEPTEMBER 24, 2015

6

Lecture 6 – The Quantum Mechanical View of Nature | The Character of Physical Law | Richard Feynman

ADDED SEPTEMBER 24, 2015

7

Lecture 7 – Seeking New Laws | The Character of Physical Law | Richard Feynman

ADDED SEPTEMBER 24, 2015

Share this:

  • Share on X (Opens in new window) X
  • Share on LinkedIn (Opens in new window) LinkedIn
  • Share on Facebook (Opens in new window) Facebook
  • Print (Opens in new window) Print
  • Email a link to a friend (Opens in new window) Email

Like this:

Like Loading…

Read Full Post »

  • Follow Blog via Email

    Enter your email address to follow this blog and receive notifications of new posts by email.

    Join 2,041 other subscribers
  • Recent Posts

    • FDA Moves Forward With Its Guidance Framework for Rare Disease Trials: 2026 August 3, 2026
    • Artificial Intelligence TRANSFORMS Medicine, Biotech and Healthcare, How? August 3, 2026
    • In Memoriam: Nobel Laureate J. Michael Bishop for discovery of Retroviral Oncogenes July 31, 2026
    • Companies Actively Engaging Artificial Intellegence for Drug Design: 2026 July 31, 2026
    • AI-Native Drug Discovery Landscape 2026 – How LPBI Group Differentiates in the New Era of Foundation Models July 19, 2026
    • In Memoriam: In Remembrance of Cancer Researchers who passed in 2026 July 13, 2026
    • Urgent Request for Action on Proposed Rule Affecting Federal Funding Grant Review July 7, 2026
    • 2026 Tang Prize in Biopharmaceutical Science Awarded to Three Pioneers of Cellular Immunotherapy Revolutionizing Treatments for Blood Cancers and Solid Tumors July 5, 2026
    • Protected: KOL on Competitive Dynamics: LPBI Group’s Founder’s Radar Screens on AI-in-Health, Life Sciences & BioPharma June 15, 2026
    • Tumor Infiltrating Lymphocytes (TIL) as a first of kind FDA approved immunotherapy for cancer June 12, 2026
  • Archives

  • Categories

  • Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org
    • 1 2012pharmaceutical
    • 1 sjwilliamspa

Powered by WordPress.com.

WPThemes.


Loading Comments...
%d